Related references
Note: Only part of the references are listed.Simvastatin Inhibits Airway Hyperreactivity Implications for the Mevalonate Pathway and Beyond
Amir A. Zeki et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial
Victor Novack et al.
INTENSIVE CARE MEDICINE (2009)
Simvastatin attenuates leukocyte recruitment in experimental bacterial meningitis
Frank Winkler et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models
Carlos J. Orihuela et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Age-Associated Inflammation and Toll-Like Receptor Dysfunction Prime the Lungs for Pneumococcal Pneumonia
Ernesto Hinojosa et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy
C. Lanaro et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Role of the manganese efflux system mntE for signalling and pathogenesis in Streptococcus pneumoniae
Jason W. Rosch et al.
MOLECULAR MICROBIOLOGY (2009)
Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin
Tamara I. Pestina et al.
MOLECULAR THERAPY (2009)
Prior Statin Use Is Associated with Improved Outcomes in Community-acquired Pneumonia
James D. Chalmers et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Preadmission Use of Statins and Outcomes After Hospitalization With Pneumonia - Population-Based Cohort Study of 29 900 Patients
Reimar W. Thomsen et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
The MACPF/CDC family of pore-forming toxins
Carlos J. Rosado et al.
CELLULAR MICROBIOLOGY (2008)
Pneumolysin: A double-edged sword during the host-pathogen interaction
Helen M. Marriott et al.
CURRENT MOLECULAR MEDICINE (2008)
Structural elements of the cholesterol-dependent cytolysins that are responsible for their cholesterol-sensitive membrane interactions
Casie E. Soltani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cytokines and plasma factors in sickle cell disease
Julia E. Brittain et al.
CURRENT OPINION IN HEMATOLOGY (2007)
Statins and sepsis: multiple modifications at multiple levels
Marius Terblanche et al.
LANCET INFECTIOUS DISEASES (2007)
Hypersusceptibility to invasive pneumococcal infection in experimental sickle cell disease involves platelet-activating factor receptor
Martha L. Miller et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Statins and the vascular endothelial inflammatory response
John Greenwood et al.
TRENDS IN IMMUNOLOGY (2007)
Platelet-activating factor receptor and innate immunity: Uptake of Gram-positive bacterial cell wall into host cells and cell-specific pathophysiology
Sophie Fillon et al.
JOURNAL OF IMMUNOLOGY (2006)
Potential therapeutic role for statins in respiratory disease
E. Hothersall et al.
THORAX (2006)
Simvastatin suppresses experimental aortic aneurysm expansion
A Kalyanasundaram et al.
JOURNAL OF VASCULAR SURGERY (2006)
β-arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae
JN Radin et al.
INFECTION AND IMMUNITY (2005)
Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury
JR Jacobson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice
JD Holtzclaw et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice
AW Rijneveld et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Prior statin therapy is associated with a decreased rate of severe sepsis
Y Almog et al.
CIRCULATION (2004)
Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin
A Solovey et al.
BLOOD (2004)
HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis
MW Merx et al.
CIRCULATION (2004)
Microarray analysis of pneumococcal gene expression during invasive disease
CJ Orihuela et al.
INFECTION AND IMMUNITY (2004)
Endothelium-dependent effects of statins
S Wolfrum et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
The degree of phenotypic correction of murine β-thalassemia intermedia following lentiviral-mediated transfer of a human γ-globin gene is influenced by chromosomal position effects and vector copy number
DA Persons et al.
BLOOD (2003)
HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells
W Dichtl et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
Y Kureishi et al.
NATURE MEDICINE (2000)